{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:36:42Z","timestamp":1791409002092,"version":"4.3.3"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,8,25]],"date-time":"2010-08-25T00:00:00Z","timestamp":1282694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1038\/npp.2010.129","type":"journal-article","created":{"date-parts":[[2010,8,25]],"date-time":"2010-08-25T10:05:24Z","timestamp":1282730724000},"page":"2462-2478","source":"Crossref","is-referenced-by-count":215,"title":["Late Prenatal Immune Activation in Mice Leads to Behavioral and Neurochemical Abnormalities Relevant to the Negative Symptoms of Schizophrenia"],"prefix":"10.1038","volume":"35","author":[{"given":"Byron KY","family":"Bitanihirwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Peleg-Raibstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forouhar","family":"Mouttet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joram","family":"Feldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,25]]},"reference":[{"key":"BFnpp2010129_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/archpsyc.60.6.565","volume":"60","author":"A Aleman","year":"2003","unstructured":"Aleman A, Kahn RS, Selten JP (2003). Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry 60: 565\u2013571.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2010129_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.neuron.2006.09.023","volume":"52","author":"PA Arguello","year":"2006","unstructured":"Arguello PA, Gogos JA (2006). Modeling madness in mice: one piece at a time. Neuron 52: 179\u2013196.","journal-title":"Neuron"},{"key":"BFnpp2010129_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0165-0173(98)00019-8","volume":"28","author":"KC Berridge","year":"1998","unstructured":"Berridge KC, Robinson TE (1998). What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28: 309\u2013369.","journal-title":"Brain Res Brain Res Rev"},{"key":"BFnpp2010129_CR4","unstructured":"Bitanihirwe BK, Weber L, Feldon J, Meyer U (2010). Cognitive impairment following prenatal immune challenge in mice correlates with prefrontal cortical AKT1 deficiency. Int J Neuropsychopharmacol in press (Epub ahead of print [PMID: 20219156])."},{"key":"BFnpp2010129_CR5","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/schbul\/sbj013","volume":"32","author":"JJ Blanchard","year":"2006","unstructured":"Blanchard JJ, Cohen AS (2006). The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr Bull 32: 238\u2013245.","journal-title":"Schizophr Bull"},{"key":"BFnpp2010129_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/schbul\/sbj052","volume":"32","author":"AS Brown","year":"2006","unstructured":"Brown AS (2006). Prenatal infection as a risk factor for schizophrenia. Schizophr Bull 32: 200\u2013202.","journal-title":"Schizophr Bull"},{"key":"BFnpp2010129_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1176\/appi.ajp.2009.09030361","volume":"167","author":"AS Brown","year":"2010","unstructured":"Brown AS, Derkits EJ (2010). Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 167: 261\u2013280.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2010129_CR8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/schbul\/sbn096","volume":"34","author":"AS Brown","year":"2008","unstructured":"Brown AS, Susser ES (2008). Prenatal nutritional deficiency and risk of adult schizophrenia. Schizophr Bull 34: 1054\u20131063.","journal-title":"Schizophr Bull"},{"key":"BFnpp2010129_CR9","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1176\/appi.ajp.2007.06081358","volume":"164","author":"RW Buchanan","year":"2007","unstructured":"Buchanan RW, Javitt DC, Marder SR, Schooler NR, Gold JM, McMahon RP et al (2007). The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. Am J Psychiatry 164: 1593\u20131602.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2010129_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0166-4328(00)00157-1","volume":"112","author":"S Cabib","year":"2000","unstructured":"Cabib S, D\u2019Amato FR, Puglisi-Allegra S, Maestripieri D (2000). Behavioral and mesocorticolimbic dopamine responses to non aggressive social interactions depend on previous social experiences and on the opponent's sex. Behav Brain Res 112: 13\u201322.","journal-title":"Behav Brain Res"},{"key":"BFnpp2010129_CR11","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/0091-3057(85)90418-6","volume":"23","author":"S Cabib","year":"1985","unstructured":"Cabib S, Puglisi-Allegra S (1985). Different effects of apomorphine on climbing behavior and locomotor activity in three strains of mice. Pharmacol Biochem Behav 23: 555\u2013557.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2010129_CR12","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/sj.npp.1300966","volume":"31","author":"B Cagniard","year":"2006","unstructured":"Cagniard B, Balsam PD, Brunner D, Zhuang X (2006). Mice with chronically elevated dopamine exhibit enhanced motivation, but not learning, for a food reward. Neuropsychopharmacology 31: 1362\u20131370.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2010129_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0306-4522(01)00171-3","volume":"105","author":"B Clancy","year":"2001","unstructured":"Clancy B, Darlington RB, Finlay BL (2001). Translating developmental time across mammalian species. Neuroscience 105: 7\u201317.","journal-title":"Neuroscience"},{"key":"BFnpp2010129_CR14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.neuro.2007.01.014","volume":"28","author":"B Clancy","year":"2007","unstructured":"Clancy B, Finlay BL, Darlington RB, Anand KJ (2007). Extrapolating brain development from experimental species to humans. Neurotoxicology 28: 931\u2013937.","journal-title":"Neurotoxicology"},{"key":"BFnpp2010129_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0166-4328(03)00221-3","volume":"149","author":"E Cohen","year":"2004","unstructured":"Cohen E, Sereni N, Kaplan O, Weizman A, Kikinzon L, Weiner I et al (2004). The relation between latent inhibition and symptom-types in young schizophrenics. Behav Brain Res 149: 113\u2013122.","journal-title":"Behav Brain Res"},{"key":"BFnpp2010129_CR16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1750-3639.2007.00096.x","volume":"17","author":"JN Crawley","year":"2007","unstructured":"Crawley JN (2007). Mouse behavioral assays relevant to the symptoms of autism. Brain Pathol 17: 448\u2013459.","journal-title":"Brain Pathol"},{"key":"BFnpp2010129_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/schbul\/23.1.63","volume":"23","author":"A Crider","year":"1997","unstructured":"Crider A (1997). Perseveration in schizophrenia. Schizophr Bull 23: 63\u201374.","journal-title":"Schizophr Bull"},{"key":"BFnpp2010129_CR18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1192\/S0007125000071919","volume":"137","author":"TJ Crow","year":"1980","unstructured":"Crow TJ (1980). Positive and negative schizophrenic symptoms and the role of dopamine. Br J Psychiatry 137: 383\u2013386.","journal-title":"Br J Psychiatry"},{"key":"BFnpp2010129_CR19","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/sj.mp.4001457","volume":"9","author":"JF Cryan","year":"2004","unstructured":"Cryan JF, Mombereau C (2004). In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 9: 326\u2013357.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2010129_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.neubiorev.2004.09.006","volume":"28","author":"JW Dalley","year":"2004","unstructured":"Dalley JW, Cardinal RN, Robbins TW (2004). Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 28: 771\u2013784.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2010129_CR21","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","volume":"148","author":"KL Davis","year":"1991","unstructured":"Davis KL, Kahn RS, Ko G, Davidson M (1991). Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148: 1474\u20131486.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2010129_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/00008877-200006000-00006","volume":"11","author":"BA Ellenbroek","year":"2000","unstructured":"Ellenbroek BA, Cools AR (2000). Animal models for the negative symptoms of schizophrenia. Behav Pharmacol 11: 223\u2013233.","journal-title":"Behav Pharmacol"},{"key":"BFnpp2010129_CR23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.mcn.2007.09.012","volume":"37","author":"F Errico","year":"2008","unstructured":"Errico F, Nistic\u00f2 R, Palma G, Federici M, Affuso A, Brilli E et al (2008). Increased levels of D-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility. Mol Cell Neurosci 37: 236\u2013246.","journal-title":"Mol Cell Neurosci"},{"key":"BFnpp2010129_CR24","doi-asserted-by":"publisher","DOI":"10.3109\/9780203007648","volume-title":"Neuropsychiatric Disorders and Infection","author":"SH Fatemi","year":"2005","unstructured":"Fatemi SH (2005). Neuropsychiatric Disorders and Infection. Martin Dunitz-Taylor & Francis Group: London, UK."},{"key":"BFnpp2010129_CR25","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/schbul\/sbn187","volume":"35","author":"SH Fatemi","year":"2009","unstructured":"Fatemi SH, Folsom TD (2009). The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull 35: 528\u2013548.","journal-title":"Schizophr Bull"},{"key":"BFnpp2010129_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.schres.2007.11.018","volume":"99","author":"SH Fatemi","year":"2008","unstructured":"Fatemi SH, Reutiman TJ, Folsom TD, Huang H, Oishi K, Mori S et al (2008). Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr Res 99: 56\u201370.","journal-title":"Schizophr Res"},{"key":"BFnpp2010129_CR27","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/sj.npp.1300066","volume":"28","author":"E Fernandez Espejo","year":"2003","unstructured":"Fernandez Espejo E (2003). Prefrontocortical dopamine loss in rats delays long-term extinction of contextual conditioned fear, and reduces social interaction without affecting short-term social interaction memory. Neuropsychopharmacology 28: 490\u2013498.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2010129_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/schbul\/16.2.211","volume":"16","author":"P Flor-Henry","year":"1990","unstructured":"Flor-Henry P (1990). Influence of gender in schizophrenia as related to other psychopathological syndromes. Schizophr Bull 16: 211\u2013227.","journal-title":"Schizophr Bull"},{"key":"BFnpp2010129_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/schbul\/sbn094","volume":"36","author":"G Foussias","year":"2010","unstructured":"Foussias G, Remington G (2010). Negative symptoms in schizophrenia: Avolition and Occam's razor. Schizophr Bull 36: 359\u2013369.","journal-title":"Schizophr Bull"},{"key":"BFnpp2010129_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00213-007-0960-3","volume":"196","author":"I Gaisler-Salomon","year":"2008","unstructured":"Gaisler-Salomon I, Diamant L, Rubin C, Weiner I (2008). Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered. Psychopharmacology 196: 255\u2013267.","journal-title":"Psychopharmacology"},{"key":"BFnpp2010129_CR31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00213-002-1311-z","volume":"166","author":"I Gaisler-Salomon","year":"2003","unstructured":"Gaisler-Salomon I, Weiner I (2003). Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol. Psychopharmacology 166: 333\u2013342.","journal-title":"Psychopharmacology"},{"key":"BFnpp2010129_CR32","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1176\/appi.ajp.158.9.1367","volume":"158","author":"DC Goff","year":"2001","unstructured":"Goff DC, Coyle JT (2001). The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 158: 1367\u20131377.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2010129_CR33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/dev.20116","volume":"48","author":"G Hava","year":"2006","unstructured":"Hava G, Vered L, Yael M, Mordechai H, Mahoud H (2006). Alterations in behavior in adult offspring mice following maternal inflammation during pregnancy. Dev Psychobiol 48: 162\u2013168.","journal-title":"Dev Psychobiol"},{"key":"BFnpp2010129_CR34","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.pbb.2006.10.015","volume":"85","author":"MD Hayward","year":"2006","unstructured":"Hayward MD, Schaich-Borg A, Pintar JE, Low MJ (2006). Differential involvement of endogenous opioids in sucrose consumption and food reinforcement. Pharmacol Biochem Behav 85: 601\u2013611.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2010129_CR35","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/0006-3223(86)90186-1","volume":"21","author":"J Hirschowitz","year":"1986","unstructured":"Hirschowitz J, Zemlan FP, Hitzemann RJ, Fleischmann RL, Garver DL (1986). Growth hormone response to apomorphine and diagnosis: a comparison of three diagnostic systems. Biol Psychiatry 21: 445\u2013454.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2010129_CR36","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1093\/schbul\/sbn083","volume":"34","author":"WP Horan","year":"2008","unstructured":"Horan WP, Blanchard JJ, Clark LA, Green MF (2008). Affective traits in schizophrenia and schizotypy. Schizophr Bull 34: 856\u2013874.","journal-title":"Schizophr Bull"},{"key":"BFnpp2010129_CR37","doi-asserted-by":"publisher","first-page":"S176","DOI":"10.1055\/s-2003-45127","volume":"36","author":"G Juckel","year":"2003","unstructured":"Juckel G, Sass L, Heinz A (2003). Anhedonia, self-experience in schizophrenia, and implications for treatment. Pharmacopsychiatry 36: S176\u2013S180.","journal-title":"Pharmacopsychiatry"},{"key":"BFnpp2010129_CR38","doi-asserted-by":"publisher","first-page":"R1596","DOI":"10.1152\/ajpcell.1994.267.6.C1543","volume":"267","author":"M Kimura","year":"1994","unstructured":"Kimura M, Toth LA, Agostini H, Cady AB, Majde JA, Krueger JM (1994). Comparison of acute phase responses induced in rabbits by lipopolysaccharide and double-stranded RNA. Am J Physiol 267: R1596\u2013R1605.","journal-title":"Am J Physiol"},{"key":"BFnpp2010129_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/026988119701100205","volume":"11","author":"MB Knable","year":"1997","unstructured":"Knable MB, Weinberger DR (1997). Dopamine, the prefrontal cortex and schizophrenia. J Psychopharmacol 11: 123\u2013131.","journal-title":"J Psychopharmacol"},{"key":"BFnpp2010129_CR40","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0893-133X(01)00396-7","volume":"27","author":"JI Koenig","year":"2002","unstructured":"Koenig JI, Kirkpatrick B, Lee P (2002). Glucocorticoid hormones and early brain development in schizophrenia. Neuropsychopharmacology 27: 309\u2013318.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2010129_CR41","doi-asserted-by":"publisher","first-page":"e6354","DOI":"10.1371\/journal.pone.0006354","volume":"4","author":"Q Li","year":"2009","unstructured":"Li Q, Cheung C, Wei R, Hui ES, Feldon J, Meyer U et al (2009). Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model. PLoS One 4: e6354.","journal-title":"PLoS One"},{"key":"BFnpp2010129_CR42","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00213-005-2210-x","volume":"179","author":"T Lipina","year":"2005","unstructured":"Lipina T, Labrie V, Weiner I, Roder J (2005). Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia. Psychopharmacology 179: 54\u201367.","journal-title":"Psychopharmacology"},{"key":"BFnpp2010129_CR43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/schbul\/sbi005","volume":"31","author":"RE Lubow","year":"2005","unstructured":"Lubow RE (2005). Construct validity of the animal latent inhibition model of selective attention deficits in schizophrenia. Schizophr Bull 31: 139\u2013153.","journal-title":"Schizophr Bull"},{"key":"BFnpp2010129_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/archpsyc.1992.01820010063008","volume":"49","author":"TH McGlashan","year":"1992","unstructured":"McGlashan TH, Fenton WS (1992). The positive-negative distinction in schizophrenia. Review of natural history validators. Arch Gen Psychiatry 49: 63\u201372.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2010129_CR45","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/archpsyc.1984.01790160098013","volume":"41","author":"HY Meltzer","year":"1984","unstructured":"Meltzer HY, Kolakowska T, Fang VS, Fogg L, Robertson A, Lewine R et al (1984). Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms. Arch Gen Psychiatry 41: 512\u2013519.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2010129_CR46","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.bbr.2008.12.022","volume":"204","author":"U Meyer","year":"2009","unstructured":"Meyer U, Feldon J (2009). Neural basis of psychosis-related behaviour in the infection model of schizophrenia. Behav Brain Res 204: 322\u2013334.","journal-title":"Behav Brain Res"},{"key":"BFnpp2010129_CR47","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.pneurobio.2009.10.018","volume":"90","author":"U Meyer","year":"2010","unstructured":"Meyer U, Feldon J (2010). Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog Neurobiol 90: 285\u2013326.","journal-title":"Prog Neurobiol"},{"key":"BFnpp2010129_CR48","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.neubiorev.2009.05.001","volume":"33","author":"U Meyer","year":"2009","unstructured":"Meyer U, Feldon J, Fatemi SH (2009a). In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci Biobehav Rev 33: 1061\u20131079.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2010129_CR49","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.neubiorev.2004.10.012","volume":"29","author":"U Meyer","year":"2005","unstructured":"Meyer U, Feldon J, Schedlowski M, Yee BK (2005). Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 29: 913\u2013947.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2010129_CR50","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.bbi.2005.11.003","volume":"20","author":"U Meyer","year":"2006","unstructured":"Meyer U, Feldon J, Schedlowski M, Yee BK (2006a). Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. Brain Behav Immun 20: 378\u2013388.","journal-title":"Brain Behav Immun"},{"key":"BFnpp2010129_CR51","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/schbul\/sbn022","volume":"35","author":"U Meyer","year":"2009","unstructured":"Meyer U, Feldon J, Yee BK (2009b). A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull 35: 959\u2013972.","journal-title":"Schizophr Bull"},{"key":"BFnpp2010129_CR52","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00213-009-1754-6","volume":"208","author":"U Meyer","year":"2010","unstructured":"Meyer U, Knuesel I, Nyffeler M, Feldon J (2010). Chronic clozapine treatment improves prenatal infection-induced working memory deficits without influencing adult hippocampal neurogenesis. Psychopharmacology 208: 531\u2013543.","journal-title":"Psychopharmacology"},{"key":"BFnpp2010129_CR53","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/sj.mp.4002042","volume":"13","author":"U Meyer","year":"2008","unstructured":"Meyer U, Murray PJ, Urwyler A, Yee BK, Schedlowski M, Feldon J (2008a). Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol Psychiatry 13: 208\u2013221.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2010129_CR54","doi-asserted-by":"publisher","first-page":"4752","DOI":"10.1523\/JNEUROSCI.0099-06.2006","volume":"26","author":"U Meyer","year":"2006","unstructured":"Meyer U, Nyffeler M, Engler A, Urwyler A, Schedlowski M, Knuesel I et al (2006b). The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 26: 4752\u20134762.","journal-title":"J Neurosci"},{"key":"BFnpp2010129_CR55","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/sj.npp.1301413","volume":"33","author":"U Meyer","year":"2008","unstructured":"Meyer U, Nyffeler M, Schwendener S, Knuesel I, Yee BK, Feldon J (2008b). Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology 33: 441\u2013456.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2010129_CR56","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.bbi.2007.09.012","volume":"22","author":"U Meyer","year":"2008","unstructured":"Meyer U, Nyffeler M, Yee BK, Knuesel I, Feldon J (2008c). Adult brain and behavioral pathological markers of prenatal immune challenge during early\/middle and late fetal development in mice. Brain Behav Immun 22: 469\u2013486.","journal-title":"Brain Behav Immun"},{"key":"BFnpp2010129_CR57","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00221-006-0419-5","volume":"173","author":"U Meyer","year":"2006","unstructured":"Meyer U, Schwendener S, Feldon J, Yee BK (2006c). Prenatal and postnatal maternal contributions in the infection model of schizophrenia. Exp Brain Res 173: 243\u2013257.","journal-title":"Exp Brain Res"},{"key":"BFnpp2010129_CR58","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/1073858406296401","volume":"13","author":"U Meyer","year":"2007","unstructured":"Meyer U, Yee BK, Feldon J (2007). The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse? Neuroscientist 13: 241\u2013256.","journal-title":"Neuroscientist"},{"key":"BFnpp2010129_CR59","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.schres.2006.01.024","volume":"84","author":"M Morrens","year":"2006","unstructured":"Morrens M, Hulstijn W, Lewi PJ, De Hert M, Sabbe BG (2006). Stereotypy in schizophrenia. Schizophr Res 84: 397\u2013404.","journal-title":"Schizophr Res"},{"key":"BFnpp2010129_CR60","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.biopsych.2005.07.031","volume":"59","author":"K Ozawa","year":"2006","unstructured":"Ozawa K, Hashimoto K, Kishimoto T, Shimizu E, Ishikura H, Iyo M (2006). Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry 59: 546\u2013554.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2010129_CR61","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1126\/science.1150196","volume":"318","author":"PH Patterson","year":"2007","unstructured":"Patterson PH (2007). Maternal effects on schizophrenia risk. Science 318: 576\u2013577.","journal-title":"Science"},{"key":"BFnpp2010129_CR62","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.bbr.2008.12.016","volume":"204","author":"PH Patterson","year":"2009","unstructured":"Patterson PH (2009). Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res 204: 313\u2013321.","journal-title":"Behav Brain Res"},{"key":"BFnpp2010129_CR63","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.bbr.2008.03.037","volume":"191","author":"D Peleg-Raibstein","year":"2008","unstructured":"Peleg-Raibstein D, Knuesel I, Feldon J (2008). Amphetamine sensitization in rats as an animal model of schizophrenia. Behav Brain Res 191: 190\u2013201.","journal-title":"Behav Brain Res"},{"key":"BFnpp2010129_CR64","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.neuroscience.2004.12.016","volume":"132","author":"D Peleg-Raibstein","year":"2005","unstructured":"Peleg-Raibstein D, Pezze MA, Ferger B, Zhang WN, Murphy CA, Feldon J et al (2005). Activation of dopaminergic neurotransmission in the medial prefrontal cortex by N-methyl-D-aspartate stimulation of the ventral hippocampus in rats. Neuroscience 132: 219\u2013232.","journal-title":"Neuroscience"},{"key":"BFnpp2010129_CR65","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbr.2004.04.008","volume":"155","author":"S Pothion","year":"2004","unstructured":"Pothion S, Bizot JC, Trovero F, Belzung C (2004). Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress. Behav Brain Res 155: 135\u2013146.","journal-title":"Behav Brain Res"},{"key":"BFnpp2010129_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00634146","volume":"50","author":"P Protais","year":"1976","unstructured":"Protais P, Costentin J, Schwartz JC (1976). Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum. Psychopharmacology 50: 1\u20136.","journal-title":"Psychopharmacology"},{"key":"BFnpp2010129_CR67","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/sj.mp.4001642","volume":"10","author":"JL Rapoport","year":"2005","unstructured":"Rapoport JL, Addington AM, Frangou S, Psych MR (2005). The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry 10: 434\u2013449.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2010129_CR68","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0920-9964(00)00162-6","volume":"51","author":"C Rascle","year":"2001","unstructured":"Rascle C, Mazas O, Vaiva G, Tournant M, Raybois O, Goudemand M et al (2001). Clinical features of latent inhibition in schizophrenia. Schizophr Res 51: 149\u2013161.","journal-title":"Schizophr Res"},{"key":"BFnpp2010129_CR69","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2165\/11530250-000000000-00000","volume":"24","author":"G Remington","year":"2010","unstructured":"Remington G, Foussias G, Agid O (2010). Progress in defining optimal treatment outcome in schizophrenia. CNS Drugs 24: 9\u201320.","journal-title":"CNS Drugs"},{"key":"BFnpp2010129_CR70","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0920-9964(99)00231-5","volume":"47","author":"MA Roy","year":"2001","unstructured":"Roy MA, Maziade M, Labb\u00e9 A, M\u00e9rette C (2001). Male gender is associated with deficit schizophrenia: a meta-analysis. Schizophr Res 47: 141\u2013147.","journal-title":"Schizophr Res"},{"key":"BFnpp2010129_CR71","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/schbul\/8.1.85","volume":"8","author":"C Schooler","year":"1982","unstructured":"Schooler C, Spohn HE (1982). Social dysfunction and treatment failure in schizophrenia. Schizophr Bull 8: 85\u201398.","journal-title":"Schizophr Bull"},{"key":"BFnpp2010129_CR72","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1523\/JNEUROSCI.23-01-00297.2003","volume":"23","author":"L Shi","year":"2003","unstructured":"Shi L, Fatemi SH, Sidwell RW, Patterson PH (2003). Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 23: 297\u2013302.","journal-title":"J Neurosci"},{"key":"BFnpp2010129_CR73","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1037\/a0016676","volume":"123","author":"P Singer","year":"2009","unstructured":"Singer P, Boison D, M\u00f6hler H, Feldon J, Yee BK (2009). Deletion of glycine transporter 1 (GlyT1) in forebrain neurons facilitates reversal learning: enhanced cognitive adaptability? Behav Neurosci 123: 1012\u20131027.","journal-title":"Behav Neurosci"},{"key":"BFnpp2010129_CR74","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00213-006-0630-x","volume":"190","author":"DA Slattery","year":"2007","unstructured":"Slattery DA, Markou A, Cryan JF (2007). Evaluation of reward processes in an animal model of depression. Psychopharmacology 190: 555\u2013568.","journal-title":"Psychopharmacology"},{"key":"BFnpp2010129_CR75","doi-asserted-by":"publisher","first-page":"10695","DOI":"10.1523\/JNEUROSCI.2178-07.2007","volume":"27","author":"SE Smith","year":"2007","unstructured":"Smith SE, Li J, Garbett K, Mirnics K, Patterson PH (2007). Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 27: 10695\u201310702.","journal-title":"J Neurosci"},{"key":"BFnpp2010129_CR76","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/dev.20170","volume":"48","author":"R Sullivan","year":"2006","unstructured":"Sullivan R, Wilson DA, Feldon J, Yee BK, Meyer U, Richter-Levin G et al (2006). The International Society for Developmental Psychobiology annual meeting symposium: impact of early life experiences on brain and behavioral development. Dev Psychobiol 48: 583\u2013602.","journal-title":"Dev Psychobiol"},{"key":"BFnpp2010129_CR77","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1196\/annals.1425.024","volume":"1136","author":"E Susser","year":"2008","unstructured":"Susser E, St Clair D, He L (2008). Latent effects of prenatal malnutrition on adult health: the example of schizophrenia. Ann N Y Acad Sci 1136: 185\u2013192.","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 9","key":"BFnpp2010129_CR78","first-page":"9","volume":"67","author":"CA Tamminga","year":"2006","unstructured":"Tamminga CA (2006). The neurobiology of cognition in schizophrenia. J Clin Psychiatry 67 (Suppl 9): 9\u201313.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2010129_CR79","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/00008877-199406000-00006","volume":"5","author":"E Tirelli","year":"1994","unstructured":"Tirelli E, Witkin JM (1994). Transient hypersensitivity to apomorphine-induced gnawing after termination of acute effects of a single high dose of cocaine. Behav Pharmacol 5: 289\u2013298.","journal-title":"Behav Pharmacol"},{"key":"BFnpp2010129_CR80","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1016\/j.lfs.2003.10.010","volume":"74","author":"TR Traynor","year":"2004","unstructured":"Traynor TR, Majde JA, Bohnet SG, Krueger JM (2004). Intratracheal double-stranded RNA plus interferon-gamma: a model for analysis of the acute phase response to respiratory viral infections. Life Sci 74: 2563\u20132576.","journal-title":"Life Sci"},{"key":"BFnpp2010129_CR81","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1523\/JNEUROSCI.5408-09.2010","volume":"30","author":"S Vuillermot","year":"2010","unstructured":"Vuillermot S, Weber L, Feldon J, Meyer U (2010). A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J Neurosci 30: 1270\u20131287.","journal-title":"J Neurosci"},{"key":"BFnpp2010129_CR82","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/00005053-198701000-00006","volume":"175","author":"CG Watson","year":"1987","unstructured":"Watson CG, Kucala T, Angulski G, Vassar P (1987). The relationships of anhedonia and the process-reactive dimension to season of birth and infectious disease incidence in schizophrenia. J Nerv Ment Dis 175: 34\u201340.","journal-title":"J Nerv Ment Dis"},{"key":"BFnpp2010129_CR83","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/archpsyc.1987.01800190080012","volume":"44","author":"DR Weinberger","year":"1987","unstructured":"Weinberger DR (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44: 660\u2013669.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2010129_CR84","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1037\/0033-2909.108.3.442","volume":"108","author":"I Weiner","year":"1990","unstructured":"Weiner I (1990). Neural substrates of latent inhibition: the switching model. Psychol Bull 108: 442\u2013461.","journal-title":"Psychol Bull"},{"key":"BFnpp2010129_CR85","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00213-002-1313-x","volume":"169","author":"I Weiner","year":"2003","unstructured":"Weiner I (2003). The \u2018two-headed\u2019 latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology 169: 257\u2013297.","journal-title":"Psychopharmacology"},{"key":"BFnpp2010129_CR86","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.bbr.2009.05.004","volume":"204","author":"I Weiner","year":"2009","unstructured":"Weiner I, Arad M (2009). Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment. Behav Brain Res 204: 369\u2013386.","journal-title":"Behav Brain Res"},{"key":"BFnpp2010129_CR87","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1017\/S1461145708009206","volume":"12","author":"C Winter","year":"2009","unstructured":"Winter C, Djodari-Irani A, Sohr R, Morgenstern R, Feldon J, Juckel G et al (2009). Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia. Int J Neuropsychopharmacol 12: 513\u2013524.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFnpp2010129_CR88","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.euroneuro.2008.06.001","volume":"18","author":"C Winter","year":"2008","unstructured":"Winter C, Reutiman TJ, Folsom TD, Sohr R, Wolf RJ, Juckel G et al (2008). Dopamine and serotonin levels following prenatal viral infection in mouse\u2014implications for psychiatric disorders such as schizophrenia and autism. Eur Neuropsychopharmacol 18: 712\u2013716.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFnpp2010129_CR89","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF03033808","volume":"14","author":"RA Wise","year":"2008","unstructured":"Wise RA (2008). Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res 14: 169\u2013183.","journal-title":"Neurotox Res"},{"key":"BFnpp2010129_CR90","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.bbr.2008.02.021","volume":"190","author":"AR Wolff","year":"2008","unstructured":"Wolff AR, Bilkey DK (2008). Immune activation during mid-gestation disrupts sensorimotor gating in rat offspring. Behav Brain Res 190: 156\u2013159.","journal-title":"Behav Brain Res"},{"key":"BFnpp2010129_CR91","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1001\/archpsyc.1986.01800120048010","volume":"43","author":"FP Zemlan","year":"1986","unstructured":"Zemlan FP, Hirschowitz J, Garver DL (1986). Relation of clinical symptoms to apomorphine-stimulated growth hormone release in mood-incongruent psychotic patients. Arch Gen Psychiatry 43: 1162\u20131167.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2010129_CR92","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1038\/sj.npp.1300248","volume":"28","author":"L Zuckerman","year":"2003","unstructured":"Zuckerman L, Rehavi M, Nachman R, Weiner I (2003). Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 28: 1778\u20131789.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2010129_CR93","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jpsychires.2004.08.008","volume":"39","author":"L Zuckerman","year":"2005","unstructured":"Zuckerman L, Weiner I (2005). Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res 39: 311\u2013323.","journal-title":"J Psychiatr Res"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2010129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2010129","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2010129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:21:51Z","timestamp":1684441311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2010129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,25]]},"references-count":93,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["BFnpp2010129"],"URL":"https:\/\/doi.org\/10.1038\/npp.2010.129","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,25]]}}}